We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Helix BioPharma Reports Issuance of U.S. Patent for the Lung Cancer-Specific Antibody Used in Its Drug Candidate L-DOS47

Product News   Mar 03, 2011

 
Helix BioPharma Reports Issuance of U.S. Patent for the Lung Cancer-Specific Antibody Used in Its Drug Candidate L-DOS47
FURTHER INFORMATION
 
 
 

Related Product News

HepaRegeniX GmbH Secures Series B Financing to Advance First Drug Candidate to the Clinic

Product News

HepaRegeniX has announced the closing of its Series B financing round, which will be used to advance an MKK4 inhibitor for the treatment of acute and chronic liver diseases

READ MORE

BioMed X Starts New Research Program in Autoimmune Diseases with Merck

Product News

BioMed X has announced the start of a new joint research group in collaboration with Merck, which will focus on the role of the intestinal epithelial barrier in the development and exacerbation of autoimmune diseases.

READ MORE

Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture

Product News

Avacta and Daewoong Pharmaceutical have announced a collaboration to develop the next generation of cell and gene therapies incorporating Affimer proteins to enhance the immune-modulatory effects.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE